BARCLAYS PLC - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 9 filers reported holding ADIAL PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$38,00015,850
+98962.5%
0.00%
Q3 2019$0160.0%0.00%
Q2 2019$0160.0%0.00%
Q1 2019$0160.00%
Other shareholders
ADIAL PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
VANGUARD GROUP INC 38,982$200,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 802$5,0000.00%
UBS Group AG 2,723$14,0000.00%
TWO SIGMA INVESTMENTS, LP 11,775$60,0000.00%
WELLS FARGO & COMPANY/MN 250$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 27,162$138,0000.00%
MORGAN STANLEY 545$3,0000.00%
BlackRock Inc. 205,684$1,053,0000.00%
View complete list of ADIAL PHARMACEUTICALS INC shareholders